Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Greg Lucier

AddedMar 31, 2024

UpdatedMay 31, 2026

Greg Lucier

Greg Lucier

Board Member, Nuvasive

Crunchbase LinkedIn

Greg Lucier's Career

Nuvasive

San Diego, CA, US

Board Member· Board

Corza Medical

Westwood, MA, US

Founder

Life Technologies

Life Technologies

Carlsbad, CA, US

Board Member· Board

Pleno

San Diego, CA, US

Board Member· Board

Epic Sciences

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Greg Lucier's Career

Nuvasive

Acquired$65.3M01997San Diego, CA, US

Board Member· Board

Leadership at Nuvasive

John DeFordBoard Member

James MarinoCo-Founder

Scott HuennekensBoard Member

Jim McKinleyCo-Founder

Vickie CappsBoard Member

Similar to Nuvasive

SpineologySt. Paul Park, MN, USMedical Devicesest. 1997SpineologySt. Paul Park, MN, US · est. 1997

Spineology, Inc.: A US-based producer and distributor of advanced medical instruments for spinal care.

Series A · $28.6M103

Spinal USAParsippany-Troy Hills, NJ, USMedical Devicesest. 2005Spinal USAParsippany-Troy Hills, NJ, US · est. 2005

Precision Spine: A US-based global provider of quality spinal products for healthcare professionals.

Angel · $258.4k75

NanovisWest Lafayette, IN, USMedical Devicesest. 2009NanovisWest Lafayette, IN, US · est. 2009

US-based Nanovis specializes in developing cervical and lumbar interbody fusion devices.

Series A · $9.5M22

OrthofixLewisville, TX, USMedical Devicesest. 1980OrthofixLewisville, TX, US · est. 1980

Orthofix Medical Inc.: Global provider of orthopedic and spine solutions, specializing in medical devices.

Corza Medical

3k2021Westwood, MA, US

Founder

Leadership at Corza Medical

Thomas TestaCEO

Life Technologies

Life Technologies

Acquired02008Carlsbad, CA, US

Board Member· Board

Leadership at Life Technologies

Noubar AfeyanFounder

Seth HoogasianBoard Member

Cheng-Pin YangBoard Member

Similar to Life Technologies

Thermo Fisher thWaltham, MA, USLaboratory Products, Scientific Instrumentsest. 2006Thermo Fisher thWaltham, MA, US · est. 2006

Global provider of scientific instruments & consumables.

Public · $119B130k

Bio-TechneMinneapolis, MN, USLife Science, Reagentsest. 1976Bio-TechneMinneapolis, MN, US · est. 1976

Bio-Techne, a Minneapolis-based medical organization, develops and sells life science solutions for research and diagnostics.

FluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Pleno

Series A$55M622017San Diego, CA, US

Board Member· Board

Leadership at Pleno

Pieter van RooyenFounder

Kim KamdarBoard Member

Similar to Pleno

Singular GenomicsSan Diego, CA, USGenomic Technologiesest. 2016Singular GenomicsSan Diego, CA, US · est. 2016

Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.

Public · $176M134

Nest GenomicsNew York City, NY, USGenomics Softwareest. 2022Nest GenomicsNew York City, NY, US · est. 2022

Nest Genomics: Comprehensive genomic software for clinical care integration and management.

OmniVisSouth San Francisco, CA, USDiagnostics, Pathogen Detectionest. 2017OmniVisSouth San Francisco, CA, US · est. 2017

OmniVis: A leading biotech startup revolutionizing pathogen detection with fast, accurate, and affordable handheld devices.

Series A · $3.5M5

Paragon GenomicsHayward, CA, USGenomic Testingest. 2015Paragon GenomicsHayward, CA, US · est. 2015

US-based Paragon Genomics, founded in 2016, provides diverse business services.

Series A · $8M22

Epic Sciences

Series G$219.5M1142008San Diego, CA, US

Board Member· Board

Leadership at Epic Sciences

Evgeny ZaytsevBoard Member

Dena MarrinucciBoard Member

Richard EglenBoard Member

James RothmanBoard Member

Murali PrahaladBoard Member

Peter KuhnFounder

Similar to Epic Sciences

Epi OneNew York City, NY, USCancer Diagnosticsest. 2016Epi OneNew York City, NY, US · est. 2016

Revolutionary cancer diagnosis platform for early prognosis, detection, and drug response.

Series B · $22.9M36

EpinomaSan Francisco, CA, USCancer Diagnosticsest. 2020EpinomaSan Francisco, CA, US · est. 2020

Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.

Pre-Seed · $125k6

OnCirc DiagnosticsBeverly Hills, CA, USCancer Diagnosticsest. 2009OnCirc DiagnosticsBeverly Hills, CA, US · est. 2009

Innovative cancer diagnostics biotech in Beverly Hills.

Pre-Seed · $500k30

Exact SciencesMadison, WI, USCancer Diagnosticsest. 1995Exact SciencesMadison, WI, US · est. 1995

Exact Sciences Corp., a US-based firm, develops non-invasive tests for early colorectal cancer detection.

Public · $2.1B6.4k

Greg Lucier's Similar Executives & Operators

Soemantri BrodjonegoroBoard Member · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

WILL WEI CHENGBoard Member · DiDi

Bo ZhangCo-Founder · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Greg Lucier

ARTHUR B COHENCo-Founder · Healthcor Management

Brady GranierFounder · BioCorRx

Santiago BibiloniCo-Founder · COR

John GardinerCo-Founder · GoVertical

Ken MorrisCo-Founder · InnovaCor